Experimental design
A 2NICE guidance (NG151) recommending aspirin for people with LSresults from the CAPP2 trial investigating the effectiveness of aspirin for people with LSinformation comparing the risks and benefits of aspirinDescription of the eight experimental conditions (vignettes) in the study and the three factors across the conditions
Participant blinding was not possible, but participants were only informed about the three factors across the vignettes after survey completion.